Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database ; volume:20 ; number:1 ; day:16 ; month:6 ; year:2020 ; pages:1-13 ; date:12.2020
BMC psychiatry ; 20, Heft 1 (16.6.2020), 1-13, 12.2020
- Creator
-
Revet, Alexis
Montastruc, François
Roussin, Anne
Raynaud, Jean-Philippe
Lapeyre-Mestre, Maryse
Nguyen, Thi Thu Ha
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12888-020-02711-z
- URN
-
urn:nbn:de:101:1-2020081321385909115498
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Revet, Alexis
- Montastruc, François
- Roussin, Anne
- Raynaud, Jean-Philippe
- Lapeyre-Mestre, Maryse
- Nguyen, Thi Thu Ha
- SpringerLink (Online service)
Other Objects (12)
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
Antidepressants
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Antidepressants and age
Antidepressants and Age
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
Pharmacovigilance in oncology
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
Antidepressants
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Antidepressants and age
Antidepressants and Age
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
Pharmacovigilance in oncology
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
Antidepressants
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Antidepressants and age
Antidepressants and Age
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database